Boston Scientific-Penumbra US premerger waiting period set to expire March 16
( February 27, 2026, 23:13 GMT | Official Statement) -- MLex Summary: Medical technology companies Boston Scientific and Penumbra submitted their US premerger notification paperwork on Feb. 13, according to a US securities filing. The waiting period for their deal is set to expire at 11:59 PM on March 16 "unless such period is terminated earlier or extended," the filing says.Excerpt:...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.